Clinical Trial

UnityPhilly Response App for Overdose Reversal

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to discover if an overdose prevention app (UnityPhilly) can encourage citizen responders to respond and prevent opioid overdoses using the UnityPhilly app. The main hypotheses to answer are: Hypothesis 1: UnityPhilly signal rates relative to EMS calls will increase over time. The primary outcome will be assessed as the total number of overdoses signaled by participants relative to all overdose-related EMS calls, per year. Hypothesis 2: The number of cases where a nearby UnityPhilly participant successfully reverses an overdose with naloxone will increase over time. The primary outcome will be assessed as the number of successful reversals relative to the total number of responder arrivals, per year. Participants will be supplied with the UnityPhilly app, training on how to use the app and respond to an opioid overdose using naloxone, and respond to follow up surveys about their experiences.
Protocol Amendment History 1 change
critical Phase changed: not specified -> not applicable 2026-07-21
Trial Details
NCT Number NCT06466005
Lead Sponsor Drexel University
Collaborators: University of Michigan
Conditions Opioid Overdose
Enrollment 450 participants
Start Date 2025-09-16
Primary Completion 2027-12 (estimated)
Study Completion 2028-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-20